NIH plans new center for promoting drug development
A National Institute of Health (NIH) advisory board has approved the creation of National Center for Advancing Translational Sciences, a move intended to accelerate…
Web Exclusives
FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug…
Medication adherence pays prompts lower healthcare costs
A study in Health Affairs found that the increased pharmacy costs associated by medication adherence was offset by a substantial savings in healthcare costs…
Compared to nsNSAIDs and coxibs, opioid use in older adults with arthritis increases risk of safety events
In older adults with arthritis, opioid use increases the risk of fractures and safety events requiring hospitalization, compared to nonselective NSAIDs (nsNSAIDs) and selective…
New report says more than 13% of Medicare patients experience adverse events during hospital stay
A new report from the Department of Health and Human Services says an estimated 13.5% of Medicare patients experience adverse events during their hospital…
RWJF launches new website
The Robert Wood Johnson Foundation (RWJF) has launched http://www.thefutureofnursing.org, a resource that includes the research and data behind the Institute of Medicine (IOM) Future…
Study shows geographic variation in prescribing patterns
A New England Journal of Medicine study of Medicare patients found that prescribing patterns varied by hospital-referral region. For example, 44% of patients in…
High-volume texting teens more likely to engage in risky behavior
Teens who text and send more than 120 messages per school day are 40% more likely to engage in risky behavior according to a…
Propoxyphene taken off market
Xanodyne Pharmaceuticals, Inc., which makes Darvon and Darvocet, the brand versions of the prescription pain medication propoxyphene, has agreed to withdraw the medication from…
Eliminating copayments improves medication adherence
When Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications, adherence to medications for diabetes, hypertension,…
FDA approves new drug for schizophrenia
The U.S. Food and Drug Administration has approved Latuda (lurasidone HCL) tables for the treatment of adults with schizophrenia. Read more here.
New lupus drug one step closer to approval
An advisory panel has recommended the U.S. Food and Drug Administration approve Benlysta; it would be the first new drug approved to treat Lupus…
NIH plans new center for promoting drug development
A National Institute of Health (NIH) advisory board has approved the creation of National Center for Advancing Translational Sciences, a move intended…
FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because…
Medication adherence pays prompts lower healthcare costs
A study in Health Affairs found that the increased pharmacy costs associated by medication adherence was offset by a substantial savings in…
Compared to nsNSAIDs and coxibs, opioid use in older adults with arthritis increases risk of safety events
In older adults with arthritis, opioid use increases the risk of fractures and safety events requiring hospitalization, compared to nonselective NSAIDs (nsNSAIDs)…
New report says more than 13% of Medicare patients experience adverse events during hospital stay
A new report from the Department of Health and Human Services says an estimated 13.5% of Medicare patients experience adverse events during…
RWJF launches new website
The Robert Wood Johnson Foundation (RWJF) has launched http://www.thefutureofnursing.org, a resource that includes the research and data behind the Institute of Medicine…
Study shows geographic variation in prescribing patterns
A New England Journal of Medicine study of Medicare patients found that prescribing patterns varied by hospital-referral region. For example, 44% of…
High-volume texting teens more likely to engage in risky behavior
Teens who text and send more than 120 messages per school day are 40% more likely to engage in risky behavior according…
Propoxyphene taken off market
Xanodyne Pharmaceuticals, Inc., which makes Darvon and Darvocet, the brand versions of the prescription pain medication propoxyphene, has agreed to withdraw the…
Eliminating copayments improves medication adherence
When Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications, adherence to medications for…
FDA approves new drug for schizophrenia
The U.S. Food and Drug Administration has approved Latuda (lurasidone HCL) tables for the treatment of adults with schizophrenia. Read more here.
New lupus drug one step closer to approval
An advisory panel has recommended the U.S. Food and Drug Administration approve Benlysta; it would be the first new drug approved to…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.